CareDx to Participate in Upcoming Investor Conferences
May 29 2024 - 7:05AM
Business Wire
CareDx, Inc. (Nasdaq: CDNA), The Transplant Company™ — a leading
precision medicine company focused on the discovery, development,
and commercialization of clinically differentiated, high-value
healthcare solutions for transplant patients and caregivers – today
announced that the Company will participate in two upcoming
investor conferences.
CareDx’s management is scheduled to present at the:
- Jefferies Global Healthcare Conference on Thursday, June
6, 2023, at 11:30 AM PT / 2:30 PM ET.
- Goldman Sachs 45th Annual Global Healthcare Conference
on Tuesday, June 11, 2023, at 1:00 PM PT / 4:00 PM ET.
To listen to the webcast, please visit the Events &
Presentations section of CareDx’s Investor Relations website at:
investors.caredxinc.com.
About CareDx – The Transplant Company
CareDx, Inc., headquartered in Brisbane, California, is a
leading precision medicine solutions company focused on the
discovery, development, and commercialization of clinically
differentiated, high-value healthcare solutions for transplant
patients and caregivers. CareDx offers testing services, products,
and digital healthcare solutions along the pre- and post-transplant
patient journey and is the leading provider of genomics-based
information for transplant patients. For more information, please
visit: www.CareDx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240529027582/en/
CareDx, Inc. Media Relations Anna Czene 818-731-2203
aczene@caredx.com
Investor Relations Greg Chodaczek Investor@caredx.com
CareDx (NASDAQ:CDNA)
Historical Stock Chart
From Jun 2024 to Jul 2024
CareDx (NASDAQ:CDNA)
Historical Stock Chart
From Jul 2023 to Jul 2024